| 0.1835 0.003 (1.38%) | 08-23 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
G Medical Innovations Holdings Ltd, along with its affiliated companies, operates as an early-stage commercial healthcare enterprise. It specializes in creating advanced mobile health and remote medical solutions for markets in the United States, China, and Israel. The company's product portfolio features Prizma, a user-friendly medical device that records vital signs, integrates with electronic medical records, and generates reports adhering to clinical standards. Another key offering is the Extended Holter Patch System, a multi-channel wearable biosensor designed for continuous electrocardiogram data collection for up to two weeks. Furthermore, it is developing a Wireless Vital Signs Monitoring System, intended for real-time and ongoing tracking of physiological parameters and biometrics. Beyond its devices, G Medical Innovations provides monitoring services, encompassing both independent diagnostic testing facility oversight and private patient monitoring. The company was established in 2014 and maintains its headquarters in Rehovot, Israel.
Mon, 31 Aug 2026
G Medical Innovations Holdings Ltd. (GMVD) Peer Comparison – Compare with Others - Value Research
Sun, 30 Aug 2026
G Medical Innovations Holdings Ltd. (GMVD) Key Financial Ratios – Valuation, Profitability & More - Value Research
Thu, 27 Aug 2026
G Medical Innovations Holdings Ltd. (GMVD) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Sun, 23 Feb 2025
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) - Share Price - intelligentinvestor.com.au
Tue, 09 Apr 2024
G Medical Innovations Holdings Ltd (GMVDF) stock price, news, quote and history - Yahoo Finance Australia
Tue, 31 May 2022
G Medical Innovations Holdings Ltd. (GMVD) - Value Research
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|